About SurgAR
SurgAR is a company based in Clermont-ferrand (France) founded in 2019. SurgAR has raised $14.39 million across 5 funding rounds from investors including BNP Paribas, Crédit Agricole and Banque Populaire. SurgAR offers products and services including AR Software. SurgAR operates in a competitive market with competitors including Augmedics, eCential Robotics, Biomodex, SentiAR and inHEART, among others.
- Headquarter Clermont-ferrand, France
-
Sectors
HealthcareTechnology
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Surgar
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$14.39 M (USD)
in 5 rounds
-
Latest Funding Round
$12.29 M (USD), Series A
Sep 26, 2024
-
Investors
BNP Paribas
& 13 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of SurgAR
SurgAR offers a comprehensive portfolio of products and services, including AR Software.
Provides real-time AR overlays for improved surgical visualization.
Funding Insights of SurgAR
SurgAR has successfully raised a total of $14.39M across 5 strategic funding rounds. The most recent funding activity was a Series A round of $12.29 million completed in September 2024. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in SurgAR
SurgAR has secured backing from 14 investors, including venture fund, institutional, and angel investors. Prominent investors backing the company include BNP Paribas, Crédit Agricole and Banque Populaire.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Mutuelles Impact is operated as an impact investment fund focused on health and social sectors.
|
Locked | Locked | Locked | |
|
UI Investissement is engaged in private equity and investment services.
|
Locked | Locked | Locked | |
|
Kreaxi is engaged in equity financing for innovative startups.
|
Locked | Locked | Locked |
Investor details for SurgAR
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by SurgAR
Investment portfolio details for SurgAR
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - SurgAR
Detailed financials for SurgAR
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Surgar Comparisons
Peer comparison for SurgAR
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of SurgAR
SurgAR operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Augmedics, eCential Robotics, Biomodex, SentiAR and inHEART, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Augmented reality systems for guiding surgical procedures are developed.
|
|
| Locked | Locked | Locked |
Robotic surgery platform for bone procedures is developed.
|
|
| Locked | Locked | Locked |
3D printed surgical simulators for medical education and patient-specific preoperative planning
|
|
| Locked | Locked | Locked |
A 3D visualization platform is offered for interventional cardiac procedures.
|
|
| Locked | Locked | Locked |
AI-based 3D cardiac models are developed for therapeutic planning.
|
|
| Locked | Locked | Locked |
Provider of mobile enterprise apps for Salesforce
|
Detailed competitors of SurgAR
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Surgar
Complete news archive for SurgAR
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about SurgAR
SurgAR was founded in 2019 and raised its 1st funding round 1 year after it was founded.
SurgAR is headquartered in Clermont-ferrand, France. It is registered at Clermont-ferrand, Auvergne-rhone-alpes, France.
Nicolas Bourdel is the current CEO of SurgAR.
SurgAR is a funded company, having raised a total of $14.39M across 5 funding rounds to date.
SurgAR was founded in 2019 in Clermont-Ferrand, France, and operates within the medical technology sector. Augmented reality software is provided for laparoscopic surgery, with features that enable automatic detection of tumors for resection. Critical anatomical structures are located and highlighted automatically. Resection margins are visualized on the organs external surface, allowing incision points to be identified by surgeons.
SurgAR's top competitors include Augmedics, eCential Robotics and LensAR.
SurgAR offers AR Software.
SurgAR has 14 investors. Key investors include BNP Paribas, Crédit Agricole, Banque Populaire, EIT Health, and Bpifrance.